Tracking Pathogens Act

Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures. S.236/H.R. 791, the Tracking COVID 19 Variants Act Issues related to genomic surveillance and sequencing H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021 H.R. 7152/S. 3534, the Tracking Pathogens Act the Advanced Research Projects Agency for Health (ARPA-H)

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

genomic sequencing and surveillance Tracking Pathogens Act (H.R.7152, S. 3534) Antimicrobial resistance (PASTEUR Act, S. 2076, STAAR Act, S. 3291) PREVENT Pandemics Act (S. 3799)

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

genomic sequencing and surveillance Tracking Pathogens Act (H.R.7152, S. 3534) Antimicrobial resistance (PASTEUR Act, S. 2076, STAAR Act, S. 3291) PREVENT Pandemics Act (S. 3799)

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement & regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932, S.4449/H.R.8188, CY23 CLFS); Precision Medicine (H.R. 6000/H.R. 5989); COVID preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463, P.L. 117-328); Future pandemic preparedness & response (S. 3799, H.R. 7152/S. 3534, H.R. 3635/S. 1974, P.L. 117-328); User Fees Reauthorization (S. 4328/H.R. 7667); ARPA-H (S. 3819/H.R. 5585); Biotechnology and biomanufacturing.

Client expense: $450,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

genomic sequencing and surveillance Tracking Pathogens Act (H.R.7152, S. 3534) Antimicrobial resistance (PASTEUR Act, S. 2076, STAAR Act, S. 3291) COVID-19 testing PREVENT Pandemics Act (S. 3799)

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues/Topics Public health funding  Behavioral health and crisis intervention Healthcare Workforce Rural health care and rural hospitals Telehealth  Medicare   Medicaid  Dual Medicare and Medicaid Eligibility Hospital Consolidation  Nutrition Services and Food Security  Obesity in older adults School meals Child nutrition Opioids and Substance Use Disorders Caregiving and Aging Home and Community Based Services Pandemic Preparedness Bills S. 3799, PREVENT Pandemics Act H.R. 6613, Keeping School Meals Flexible Act S. 1536 / H.R. 3108, Medical Nutrition Therapy Act of 2021 H.R. 5218, Collaborate in an Orderly and Cohesive Manner H.R. 7232, 9-8-8 and Parity Assistance Act of 2022 H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022 H.R. 1887 / S. 4009, Rural Hospital Support Act S. 2089, Keep Kids Fed Act S. 3913 / H.R. 8481, Improving DATA in Public Health Act S.4264, Advancing Integration in Medicare and Medicaid (AIM) Act S.3534 / H.R.7152, Tracking Pathogens Act S. 1162 / H.R. 6770, PACE Plus Act S.3626, PACE Expanded Act S. 569 / H.R. 1577, Treat and Reduce Obesity Act H.R. 4040, Advancing Telehealth Beyond COVID-19 Act of 2021

Client expense: $860,000 · Firm income: Not reported

Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).

Client expense: $870,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities. Draft Graduate Medical Education Reform Act Issue: Support increased funding for the National Health Service Corps, Teaching Health Center GME, and National Disaster Medical Service (NDMS) demonstration pilot. Support increased Medicare support for Graduate Medical Education/physician training. Issues: Educate Congress and the administration about the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support measures to expand access to mental health care and substance use disorder treatment, including funding for training on substance use disorders, pain management, and safe prescribing practices, enhance enforcement of mental health parity laws, increased financial support for integrated behavioral health models, and the removal of regulatory barriers to telehealth-enabled mental health care, including electronic interprofessional consults (eConsults). Support Senate Finance Committee proposal to provide 400 additional Medicare-supported graduate medical education slots for psychiatry and psychiatry sub-specialties. H.R. 1384/ S.445 Mainstreaming Addiction Treatment (MAT) Act of 2021 Issue: Support suspension of waiver requirement for certain providers to prescribe buprenorphine. H.R. 2067 Medication Access and Training Expansion Act of 2021 Issue: Oppose legislative mandates dictating medical education curriculum on pain management and addiction. H.R. 7236 Strengthen Kids Mental Health Now Act Issue: Support increasing Medicaid reimbursement rates for pediatric mental health services through a 100% federal match. P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels. Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers to fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including not providing 340B discounts on covered drugs purchased at community pharmacies. H.R. 4390 Preserving Rules Ordered for the Entities Covered Through 340B Act of 2021 (PROTECT 340B Act) Issue: Support measures to prevent pharmacy benefit managers and commercial insurers from discriminating against 340B covered entities. H.R. 3203/S. 773 Issue: Support policy to allow 340B DSH hospitals to remain eligible to participate in the program throughout the current public health emergency even if their DSH adjustment falls below the current threshold due to changes in payor mix as a result of the COVID-19 pandemic. Issue: Oppose insurance plans that do not meet Affordable Care Act requirements. Issue: Support increased interoperability and exchange of electronic health information and delayed enforcement of information blocking rule until comprehensive guidance is issued. Issue: Support the ongoing refinement of the two new mandatory alternative payment models, the Radiation Oncology Model and End-stage Renal Disease Treatment Choices Model, to better incentivize high-quality care for all patients. H.R. 4128/ S. 2209 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 Issue: Educate Congress on development of Laboratory Developed Tests at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing Food and Drug Administration regulation of the development of Laboratory Developed Tests at academic medical centers. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 H.R. 7667, Food and Drug Amendments of 2022 (FDA22) Issue: Support promotion of data sharing and clinical trials results reporting. Support increased clinical trials diversity. Issue: Development of Enhanced Primary Care Pilot Act proposal Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity. H.R. 2503 Social Determinants Accelerator Act of 2021 Issue: Support grants to address social determinants of health H.R. 7585 / S. 4486, Health Equity and Accountability Act Issue: Support programs to improve health equity and address social determinants of health. Issue: Support incentives to encourage the inclusion of implicit bias training in medical education and residency training. Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health. Issue: Support maternal health initiatives to expand coverage for postpartum women and expand demonstration project grants. H.R. 959 Black Maternal Health Momnibus Act of 2021 S. 1695 / H.R. 4387 Maternal Health Quality Improvement Act S. 1491/ H.R. 769 Rural MOMs Act H.R. 4387 Maternal Health Quality Improvement Act of 2021 H.R. 5376, Build Back Better Act H.R. 925 / S. 347 Data to Save Moms Act Issue: Support legislative efforts to improve maternal health and reduce rates of maternal mortality, including the Momnibus. Support legislative initiatives to improve data collection to improve maternal health equity. P.L. 117-159, Bipartisan Safer Communities Act Issue: Support policies to promote firearm safety, universal background checks, violence prevention programs, extreme risk protection orders, child access safety laws, reinstating assault weapons ban, data infrastructure, hospital based and community violence intervention programs, and programs to address mental and behavioral health impact of gun violence. Issue: Support funding for Community Violence Interventions/ Hospital Based Violence Intervention Programs P.L. 117-105, Dr. Lorna Breen Health Care Provider Protection Act Issue: Support grants directed at improving clinician burnout and well-being. Issue: Provide feedback on implementation of the Provider Relief Fund. Support extension for use of PRF funds. Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs, including delaying recoupment of MAAP loans. Issue: Support extension of public health emergency declaration. Issue: Provide feedback on COVID-19 and pandemic response. Provide feedback on monkeypox response including testing. S. 3799, PREVENT Pandemics Act Issue: Provide feedback on pandemic preparedness legislation, urge inclusion of provisions to support academic medical centers preparedness activities. Issue: Support establishment of regional pandemic response centers, stronger linkages between public health and academic medicine, and the role of medical students and academic medical centers in administering COVID vaccines. H.R. 8131 Increasing Competition for Medical Residency Act Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency. Issue: Support efforts of academic medical centers to respond to public health threats such as monkeypox and COVID-19. Urge establishment and implementation of robust national testing strategy; functional, redundant, and transparent supply chain; improved federal coordination; investments in public health and health care human and other resources; data modernization initiatives; and other actions to improve current and future pandemic response. H.R. 708, S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout the COVID-19 public health emergency S. 674 Public Health Infrastructure Saves Lives Act Issue: Support investments in core public health infrastructure. Issue: Support ensuring patients are put first, that conscience protections align with medical professionalism standards, and oppose interference in the patient-physician relationship. Issue: Support increased interoperability and exchange of electronic health information. Support delay of enforcement beyond April 2021. H.R. 6000, Cures 2.0 Act Issue: Provide feedback on provisions related to public health, patients and caregivers, FDA, CMS, and research, and ARPA-H. Issue: Promote strategies to strengthen the health, public health, and research workforces. H.R. 3671, Doctors of Community Act Issue: Discuss authorization of the Teaching Health Center Graduate Medical Education program. Issue: Provide guidance on the implementation of the No Surprises Act. Issue: Provide feedback on proposed modifications to the HIPAA privacy rule. H.R. 5035, S. 2982 Child Suicide Prevention and Lethal Means Safety Act Issue: Support legislation to provide grants to improve suicide prevention and lethal means safety. Issue: Inform Congress and Administration about medical education on caring for older adults, nutrition, climate change, stigma around addiction, reproductive health, and accelerated medical education training programs. Issue: Provide feedback on efforts of the academic medicine community to address climate change and decarbonization. H.R. 7152/ S.3534, The Tracking Pathogens Act Issue: Support expansion of CDC activities related to genomic sequencing of pathogens. Issue: Support reignition of Cancer Moonshot. H.R. 7961 - Safety from Violence for Healthcare Employees (SAVE) Act Issue: Support statutory protections against violence and intimidation for healthcare workers and provide grants for hospital programs aimed at preventing violence in healthcare settings. Issue: Support a one-year pause in military medical billet reductions in the Military Health System.

Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Ongoing monitoring of CDC surveillance funding; Chips and Science Act (PL 117-167); H.R. 791/S. 236, Tracking COVID-19 Variants Act; H.R. 5376, Inflation Reduction Act of 2022; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; Issues related to the FY 2023 President's Budget; S.3534/H.R.7152, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures. S.236/H.R. 791, the Tracking COVID 19 Variants Act Issues related to genomic surveillance and sequencing H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021 H.R. 7152/S. 3534, the Tracking Pathogens Act the Advanced Research Projects Agency for Health (ARPA-H)

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

genomic sequencing and surveillance Tracking Pathogens Act (H.R.7152, S. 3534) Antimicrobial resistance (PASTEUR Act, S. 2076, STAAR Act, S. 3291) COVID-19 testing PREVENT Pandemics Act (S. 3799)

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities. Draft Graduate Medical Education Reform Act Issue: Support increased funding for the National Health Service Corps, Teaching Health Center GME, and National Disaster Medical Service (NDMS) demonstration pilot. Support increased Medicare support for Graduate Medical Education/physician training. Issues: Educate Congress and the administration about the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support measures to expand access to mental health care and substance use disorder treatment, including funding for training on substance use disorders, pain management, and safe prescribing practices, enhance enforcement of mental health parity laws, increased financial support for integrated behavioral health models, and the removal of regulatory barriers to telehealth-enabled mental health care, including electronic interprofessional consults (eConsults). H.R. 1384/ S.445 Mainstreaming Addiction Treatment (MAT) Act of 2021 Issue: Support suspension of waiver requirement for certain providers to prescribe buprenorphine. H.R. 2067 Medication Access and Training Expansion Act of 2021 Issue: Oppose legislative mandates dictating medical education curriculum on pain management and addiction. H.R. 7236 Strengthen Kids Mental Health Now Act Issue: Support increasing Medicaid reimbursement rates for pediatric mental health services through a 100% federal match. P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels. Issue: Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including not providing 340B discounts on covered drugs purchased at community pharmacies. H.R. 4390 Preserving Rules Ordered for the Entities Covered Through 340B Act of 2021 (PROTECT 340B Act) Issue: Support measures to prevent pharmacy benefit managers and commercial insurers from discriminating against 340B covered entities. H.R. 3203/S. 773 Issue: Support policy to allow 340B DSH hospitals to remain eligible to participate in the program throughout the current public health emergency even if their DSH adjustment falls below the current threshold due to changes in payor mix as a result of the COVID-19 pandemic. Issue: Oppose insurance plans that do not meet Affordable Care Act requirements. Issue: Support increased interoperability and exchange of electronic health information and delayed enforcement of information blocking rule until comprehensive guidance is issued. Issue: Support the ongoing refinement of the two new mandatory alternative payment models, the Radiation Oncology Model and End-stage Renal Disease Treatment Choices Model, to better incentivize high-quality care for all patients. H.R. 4128/ S. 2209 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 Issue: Educate Congress on development of Laboratory Developed Tests at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care. Issue: Development of Enhanced Primary Care Pilot Act proposal H.R.7585, Health Equity and Accountability Act Issue: Support programs to improve health equity and address social determinants of health. Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity. H.R. 2503 Social Determinants Accelerator Act of 2021 Issue: Support grants to address social determinants of health Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health. Issue: Support maternal health initiatives to expand coverage for postpartum women and expand demonstration project grants. H.R. 959 Black Maternal Health Momnibus Act of 2021 S. 1695 / H.R. 4387 Maternal Health Quality Improvement Act S. 1491/ H.R. 769 Rural MOMs Act H.R. 4387 Maternal Health Quality Improvement Act of 2021 H.R. 5376, Build Back Better Act H.R. 925 / S. 347 Data to Save Moms Act Issue: Support legislative efforts to improve maternal health and reduce rates of maternal mortality, including the Momnibus. Support legislative initiatives to improve data collection to improve maternal health equity. P.L. 117-159, Bipartisan Safer Communities Act Issue: Support policies to promote firearm safety, universal background checks, violence prevention programs, extreme risk protection orders, child access safety laws, reinstating assault weapons ban, data infrastructure, hospital based and community violence intervention programs, and programs to address mental and behavioral health impact of gun violence. Issue: Support funding for Community Violence Interventions/ Hospital Based Violence Intervention Programs P.L. 117-105, Dr. Lorna Breen Health Care Provider Protection Act Issue: Support grants directed at improving clinician burnout and well-being. Issue: Provide feedback on implementation of the Provider Relief Fund. Support extension for use of PRF funds. Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs, including delaying recoupment of MAAP loans. Issue: Support extension of public health emergency declaration. Issue: Provide feedback on COVID-19 and pandemic response. S. 3799, PREVENT Pandemics Act Issue: Provide feedback on pandemic preparedness legislation, urge inclusion of provisions to support academic medical centers preparedness activities. Issue: Support establishment of regional pandemic response centers, stronger linkages between public health and academic medicine, and the role of medical students and academic medical centers in administering COVID vaccines. Issue: Support efforts of academic medical centers to respond to public health threats such as monkeypox and COVID-19. Urge establishment and implementation of robust national testing strategy; functional, redundant, and transparent supply chain; improved federal coordination; investments in public health and health care human and other resources; data modernization initiatives; and other actions to improve current and future pandemic response. H.R. 708, S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout the COVID-19 public health emergency S. 674 Public Health Infrastructure Saves Lives Act Issue: Support investments in core public health infrastructure. Issue: Support ensuring patients are put first, that conscience protections align with medical professionalism standards, and oppose interference in the patient-physician relationship. Issue: Support increased interoperability and exchange of electronic health information. Support delay of enforcement beyond April 2021. S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022 H.R. 7667, Food and Drug Amendments of 2022 (FDA22) Issue: Support promotion of data sharing and clinical trials results reporting. Support increased clinical trials diversity. H.R. 6000, Cures 2.0 Act Issue: Provide feedback on provisions related to public health, patients and caregivers, FDA, CMS, and research, and ARPA-H. Issue: Promote strategies to strengthen the health, public health, and research workforces. H.R. 3671, Doctors of Community Act Issue: Discuss authorization of the Teaching Health Center Graduate Medical Education program. Issue: Provide guidance on the implementation of the No Surprises Act. Issue: Provide feedback on proposed modifications to the HIPAA privacy rule. H.R. 5035, S. 2982 Child Suicide Prevention and Lethal Means Safety Act Issue: Support legislation to provide grants to improve suicide prevention and lethal means safety. Issue: Inform Congress about medical education on caring for older adults, nutrition, climate change, and opportunities to accelerate training. Issue: Provide feedback on efforts of the academic medicine community to address climate change and decarbonization. H.R. 7152/ S.3534, The Tracking Pathogens Act Issue: Support expansion of CDC activities related to genomic sequencing of pathogens. Issue: Support reignition of Cancer Moonshot. Issue: Educate Congress on accelerated medical education programs. Issue: Educate Congress and the administration on AAMC member curriculum on climate change and nutrition.

Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues/Topics Public health funding  Behavioral health and crisis intervention Healthcare Workforce Rural health care and rural hospitals Telehealth  Medicare   Medicaid  Dual Medicare and Medicaid Eligibility Hospital Consolidation     Nutrition Services and Food Security  Obesity in older adults School meals Child nutrition Opioids and Substance Use Disorders Caregiving and Aging Home and Community Based Services Pandemic Preparedness Bills S3799 PREVENT Pandemics Act H.R. 6613 - Keeping School Meals Flexible Act S1536/HR3108 - Medical Nutrition Therapy Act of 2021 HR 5218 - Collaborate in an Orderly and Cohesive Manner HR 7232 - 9-8-8 and Parity Assistance Act of 2022 HR 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 H.R.1887/ S.4009 - Rural Hospital Support Act S.2089 - Keep Kids Fed Act H.R.6613 - Keeping School Meals Flexible Act S.3913 - Improving DATA in Public Health Act S.4264 - Advancing Integration in Medicare and Medicaid (AIM) Act S.3534/HR.7152 - Tracking Pathogens Act

Client expense: $720,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Ongoing monitoring of CDC surveillance funding; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R.791/S.236, Tracking COVID-19 Variants Act; H.R. 5376, Build Back Better Act; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; Issues related to the FY 2023 Presidents Budget S.3534/H.R.7152, Tracking Pathogens Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE

Support S. 674, the Public Health Infrastructure Saves Lives Act. Support H.R. 3297, the Public Health Workforce Loan Repayment Act. Support the Women's Health Protection Act. S. 3534, the Tracking Pathogens Act in the PREVENT Pandemics Act. Support expanded child care and nutrition provisions included in the House-passed Build Back Better Act. Support legislation to provide federal agencies with the flexibilities and funding needed to shore up supply and assure the safety of infant formula available on the market. Support the Stop Anti-Abortion Disinformation Act. Support the Affordability is Access Act.

Client expense: $26,614 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office

Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine H.R. 6000/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534, H.R. 3635/S. 1974); Cancer Moonshot 2.0; Health Equity; User Fees Reauthorization (S. 4328/H.R. 7667); and ARPA-H (S. 3819/H.R. 5585).

Client expense: $580,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures. S.236/H.R. 791, the Tracking COVID 19 Variants Act Issues related to genomic surveillance and sequencing H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021 H.R. 7152/S. 3534, the Tracking Pathogens Act the Advanced Research Projects Agency for Health (ARPA-H)

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R.2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act

Client expense: Not reported · Firm income: $60,000

Government targets: SENATE

Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Implementation of American Rescue Plan Act of 2021 (PL 117-2); Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260); Ongoing monitoring of CDC surveillance funding; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R.791/S.236, Tracking COVID-19 Variants Act; H.R. 5376, Build Back Better Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; Issues related to the FY 2023 Presidents Budget S.3534/H.R.7152, Tracking Pathogens Act

Client expense: Not reported · Firm income: $60,000

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities. Draft Graduate Medical Education Reform Act Issue: Support increased funding for the National Health Service Corps, Teaching Health Center GME, and National Disaster Medical Service (NDMS) demonstration pilot. Support increased Medicare support for Graduate Medical Education/physician training. Issues: Educate Congress and the administration about academic medicines response to the opioid epidemic. Support funding for training on substance use disorders, pain management, and safe prescribing practices. Support suspension of DATA waivers and new guidelines to expand access to buprenorphine. Support continuation of telehealth flexibilities allowing authorized practitioners to prescribe buprenorphine. Issue: Educate Congress on the role of academic medicine in the provision of mental and behavioral health care. Support measures to expand access to mental health care, including enhanced enforcement of mental health parity laws, expanded funding for integrated behavioral health models, and the removal of regulatory barriers to telehealth-enabled mental health care, including electronic interprofessional consults (eConsults). H.R. 1384/ S.445 Mainstreaming Addiction Treatment (MAT) Act of 2021 Issue: Support suspension of waiver requirement for certain providers to prescribe buprenorphine. P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels. Issue: Support high-quality affordable health insurance. Support programs and funds for safety-net providers. Issue: Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including not providing 340B discounts on covered drugs purchased at community pharmacies. H.R. 3203/S. 773 Issue: Support policy to allow 340B DSH hospitals to remain eligible to participate in the program throughout the current public health emergency even if their DSH adjustment falls below the current threshold due to changes in payor mix as a result of the COVID-19 pandemic. Issue: Oppose insurance plans that do not meet Affordable Care Act requirements. Issue: Support increased interoperability and exchange of electronic health information and delayed enforcement of information blocking rule until comprehensive guidance is issued. Issue: Support the ongoing refinement of the two new mandatory alternative payment models, the Radiation Oncology Model and End-stage Renal Disease Treatment Choices Model, to better incentivize high-quality care for all patients. H.R. 4128/ S. 2209 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 Issue: Educate Congress on development of Laboratory Developed Tests and impact of burdensome regulation on patients access to care at academic medical centers. Issue: Development of Enhanced Primary Care Pilot Act proposal Draft Health Equity and Accountability Act Issue: Support programs to improve health equity and address social determinants of health. Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity. H.R. 2503 Social Determinants Accelerator Act of 2021 Issue: Support grants to address social determinants of health Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health. Issue: Support maternal health initiatives to expand coverage for postpartum women and expand demonstration project grants. H.R. 959 Black Maternal Health Momnibus Act of 2021 S. 1695 / H.R. 4387 Maternal Health Quality Improvement Act S. 1491/ H.R. 769 Rural MOMs Act H.R. 4387 Maternal Health Quality Improvement Act of 2021 H.R. 5376, Build Back Better Act H.R. 925 / S. 347 Data to Save Moms Act Issue: Support legislative efforts to improve maternal health and reduce rates of maternal mortality, including the Momnibus. Support legislative initiatives to improve data collection to improve maternal health equity. Issue: Support policies to promote firearm safety, universal background checks, violence prevention programs, extreme risk protection orders, child access safety laws, and reinstating assault weapons ban. Issue: Support funding for Community Violence Interventions/ Hospital Based Violence Intervention Programs P.L. 117-105, Dr. Lorna Breen Health Care Provider Protection Act Issue: Support grants directed at improving clinician burnout and well-being. Issue: Provide feedback on implementation of the Provider Relief Fund. Support extension for use of PRF funds. Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs, including delaying recoupment of MAAP loans. Issue: Support extension of public health emergency declaration. Issue: Provide feedback on COVID-19 and pandemic response. S. 3799, PREVENT Pandemics Act Issue: Provide feedback on pandemic preparedness legislation, urge inclusion of provisions to support academic medical centers preparedness activities. Issue: Support establishment of regional pandemic response centers, stronger linkages between public health and academic medicine, and the role of medical students and academic medical centers in administering COVID vaccines. Issue: Urge establishment and implementation of robust national COVID-19 testing strategy; functional, redundant, and transparent supply chain; improved federal coordination; investments in public health and health care human and other resources; data modernization initiatives; and other actions to improve current and future pandemic response. H.R. 708, S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout the COVID-19 public health emergency S. 674 Public Health Infrastructure Saves Lives Act Issue: Support investments in core public health infrastructure. Issue: Support ensuring patients are put first, that conscience protections align with medical professionalism standards, and oppose interference in the patient-physician relationship. Issue: Support increased interoperability and exchange of electronic health information. Support delay of enforcement beyond April 2021. Issue: Support robust research agenda for the Patient-Centered Outcomes Research Institute. Issue: Support promotion of data sharing and clinical trials results reporting. H.R. 6000, Cures 2.0 Act Issue: Provide feedback on provisions related to public health, patients and caregivers, FDA, CMS, and research, and ARPA-H. Issue: Promote strategies to strengthen the health, public health, and research workforces. H.R. 3671, Doctors of Community Act Issue: Discuss authorization of the Teaching Health Center Graduate Medical Education program. Issue: Provide guidance on the implementation of the No Surprises Act. Issue: Provide feedback on proposed modifications to the HIPAA privacy rule. H.R. 5035, S. 2982 Child Suicide Prevention and Lethal Means Safety Act Issue: Support legislation to provide grants to improve suicide prevention and lethal means safety. Issue: Inform about medical education on caring for older adults, nutrition, climate change, and opportunities to accelerate training. H.R. 7152/ S.3534, The Tracking Pathogens Act Issue: Support expansion of CDC activities related to genomic sequencing of pathogens. Issue: Support reignition of Cancer Moonshot. HR 5035, The Child Suicide Prevention and Lethal Means Safety Act Issue: Support expansion of training for health professionals to prevent self-harm or suicide

Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures. S.236/H.R. 791, the Tracking COVID 19 Variants Act Issues related to genomic surveillance and sequencing H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021 H.R. 7152/S. 3534, the Tracking Pathogens Act

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

genomic sequencing and surveillance Tracking Pathogens Act (H.R.7152, S. 3534) Antimicrobial resistance (PASTEUR Act, S. 2076, STAAR Act, S. 3291) COVID-19 testing PREVENT Pandemics Act (S. 3799)

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Strengthening public health infrastructure, workforce and data in preparation for the next pandemic; Tracking Pathogens Act (S. 3534); PREVENT Pandemics Act (S. 3799); Disease X Act (S. 2640); Newborn Screening Saves Lives Reauthorization Act (H.R. 482).

Client expense: Not reported · Firm income: $20,000

Support S. 674, the Public Health Infrastructure Saves Lives Act. Support H.R. 3297, the Public Health Workforce Loan Repayment Act. Support the Women's Health Protection Act. S. 3534, the Tracking Pathogens Act in the PREVENT Pandemics Act. Support provisions in the PREVENT Pandemics Act. Support health coverage provisions included in the House-passed Build Back Better Act. Support expanded child care and nutrition provisions included in the House-passed Build Back Better Act.

Client expense: $32,628 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office

Allergy policies (S. 701/H.R. 4114); Diagnostic test reimbursement and regulatory policies (S. 2209/H.R. 4128, S. 2076/H.R. 3932); Precision Medicine (CURES 2.0/H.R. 5989); COVID-19 preparedness products and services; Healthcare supply chain (S. 1693/H.R. 3463); Future pandemic preparedness and response (S. 3799, H.R. 7152/S.3534); Cancer Moonshot 2.0; Health Equity.

Client expense: $740,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

AACC joined with other healthcare groups in writing to the Senate HELP leadership endorsing S.3534, the Tracking Pathogens Act, which would support and enhance existing genomic sequencing and surveillance activities. AACC met with House and Senate staff urging that the Verifying Accurate Leading-edge IVCT Development (VALID) Act not be included in the Medical Device User Fee Amendments V legislative package that will be considered by Congress. AACC provided input to the Senate HELP committee on its draft "Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act," which would rebuild and strengthen our nations public health infrastructure.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Healthcare issues related to clinical laboratories; H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests; Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests; H.R. 6202, the Telehealth Extension Act, and S. 3593, the Telehealth Extension and Evaluation Act, provisions relating to extension of Medicare coverage of telehealth services and limitations on payment for certain laboratory tests; S. 3534, the Tracking Pathogens Act, provisions relating to genomic sequencing of variants of the SARS-CoV-2 virus; S. 3799, the PREVENT Pandemics Act, and a draft of the Improving DATA in Public Health Act, provisions relating to demographic data reporting obligations for laboratories; Federal policy related to the National Correct Coding Initiative and manual instructions inconsistent with American Medical Association guidelines for Current Procedural Terminology (CPT) coding; H.R. 2144, the Access to Genetic Counselor Services Act, provisions relating to Medicare coverage of genetic counselor services; H.R. 4144/S. 2022, the Ending the Diagnostic Odyssey Act, provisions relating to coverage of whole genome sequencing services for certain individuals; H.R. 5030/S. 2706, the DIVERSE Trials Act, provisions relating to enhancing diversity in clinical trials and data collection and reporting by clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 6000, the Cures 2.0 Act, provisions relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing; H.R. 4144/S. 2022, the Ending the Diagnostic Odyssey Act, provisions relating to coverage of whole genome sequencing services for certain individuals; and H.R. 6875, the Right Drug Dose Now Act, provisions relating to use of pharmacogenetic information; H.R. 2565/S. 2952, the FDA Modernization Act, provisions relating to biomedical research; and Federal policy relating to CDC funding for standardization of pediatric reference range intervals and laboratory result harmonization.